CFD validation using in-vitro MRI velocity data – Methods for data matching and CFD error quantification

Predicting blood flow velocities in patient-specific geometries with Computational Fluid Dynamics (CFD) can provide additional data for diagnosis and treatment planning but the solution can be inaccurate. Therefore, it is crucial to understand the simulation errors and calibrate the numerical model....

Full description

Saved in:
Bibliographic Details
Published inComputers in biology and medicine Vol. 131; p. 104230
Main Authors Wüstenhagen, Carolin, John, Kristine, Langner, Sönke, Brede, Martin, Grundmann, Sven, Bruschewski, Martin
Format Journal Article
LanguageEnglish
Published United States Elsevier Ltd 01.04.2021
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0010-4825
1879-0534
1879-0534
DOI10.1016/j.compbiomed.2021.104230

Cover

More Information
Summary:Predicting blood flow velocities in patient-specific geometries with Computational Fluid Dynamics (CFD) can provide additional data for diagnosis and treatment planning but the solution can be inaccurate. Therefore, it is crucial to understand the simulation errors and calibrate the numerical model. In-vitro velocity-encoded MRI is a versatile tool to validate CFD. The comparison between CFD and in-vitro MRI velocity data, and the analysis of the simulation error are the objectives of this study. A three-step routine is presented to validate medical CFD data. First, a properly scaled model of the patient-specific geometry is fabricated to achieve high relative resolution in the MRI experiment. Second, the measured flow geometry is matched with the CFD data using one of two algorithms, Coherent Point Drift and Iterative Closest Point. The aligned data sets are then interpolated onto a common grid to enable a point-to-point comparison. Third, the global and local deviations between CFD and MRI velocity data are calculated using different algorithms to reliably estimate the simulation error. The routine is successfully tested with a patient-specific model of a cerebral aneurysm. In conclusion, the methods presented here provide a framework for CFD validation using in-vitro MRI velocity data. [Display omitted] •Framework for CFD validation with in-vitro 3D MRI velocity data.•Automatic alignment of numerical and experimental data via data matching.•Quantification and visualization of the CFD simulation error.•Minimal user input enables automated evaluation.•Demonstration of the process with a patient-specific cerebral aneurysm model.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0010-4825
1879-0534
1879-0534
DOI:10.1016/j.compbiomed.2021.104230